Author

K. D. Rodland

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:protein folding & dynamics· 1 Research Focus:spatial domain detection· 1

Frequent Co-Authors

C.-F. Tsai· 2 shared T. Liu· 2 shared A. Burian· 1 shared A. G. Paulovich· 1 shared C. H. Wasserfall· 1 shared C. Lin· 1 shared C.-C. Hsu· 1 shared G. Longton· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

C.-F. Tsai

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A streamlined tandem tip-based workflow for sensitive nanoscale phosphoproteomics

C.-F. Tsai, Y.-T. Wang, C.-C. Hsu, R. B. Kitata, R. K. Chu, M. Velickovic, R. Zhao, S. M. Williams, W. B. Chrisler, M. L. Jorgensen, R. J. Moore, Y. Zhu, K. D. Rodland, R. D. Smith, C. H. Wasserfall, , T. Liu

This paper introduces a streamlined phosphoproteomics workflow that reduces sample loss and processing time, enabling sensitive detection of phosphopeptides from nanoscale samples.

bioRxiv · Apr 12, 2022Biochemistry

Multiplexed triage of candidate biomarkers in plasma using internal standard triggered-parallel reaction monitoring mass spectrometry

J. J. Kennedy, J. R. Whiteaker, R. G. Ivey, A. Burian, S. Chowdhury, C.-F. Tsai, T. Liu, C. Lin, O. Murillo, R. A. Lundeen, L. A. Jones, P. R. Gafken, G. Longton, K. D. Rodland, S. Skates, , A. G. Paulovich

This paper introduces an IS-PRM assay to prioritize plasma biomarkers for validation, showing improved sensitivity and precision over traditional methods.

bioRxiv · Sep 2, 2021 · PreprintCancer Biology